Clinical trials
Terminated Phase 2 Osteosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BTG International Inc. | 1 |
| City of Hope Medical Center | 1 |
| Davidzon, Guido, M.D. | 1 |
| Emerald Clinical Inc. | 1 |
| Ipsen | 1 |
| Italian Sarcoma Group | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Monica Thakar | 1 |
| National Cancer Institute (NCI) | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 16 |
| Sarcoma | 5 |
| Neuroectodermal Tumors, Primitive, Peripheral | 2 |
| Sarcoma, Ewing | 2 |
| Bone Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Cardiotoxicity | 1 |
| Central Nervous System Neoplasms | 1 |
| Chondrosarcoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.